Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Sexual Dysfunction Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Sexual Dysfunction Drugsmarket, defines the market attractiveness level of Sexual Dysfunction Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Sexual Dysfunction Drugs industry, describes the types of Sexual Dysfunction Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sexual Dysfunction Drugs market and the development prospects and opportunities of Sexual Dysfunction Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sexual Dysfunction Drugs market in Chapter 13.
By Player:
GlaxoSmithKline
Teva Pharmaceutical Industries
Pfizer
Eli Lilly
Emotional Brain
S1 Biopharma
Apricus Biosciences
Bayer
Leadiant Biosciences
NexMed
Takeda
Vietstar Biomedical Research
Ivix LLX
Merck
AbbVie
By Type:
Oral Therapy
Intracavernosal Therapy
Hormonal Therapy
Transurethral Therapy
By End-User:
Male
Female
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Sexual Dysfunction Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Sexual Dysfunction Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Sexual Dysfunction Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Sexual Dysfunction Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Sexual Dysfunction Drugs Market Analysis and Outlook to 2022
-
7.1 Global Sexual Dysfunction Drugs Consumption (2017-2022)
-
7.2 United States Sexual Dysfunction Drugs Consumption (2017-2022)
-
7.3 Europe Sexual Dysfunction Drugs Consumption (2017-2022)
-
7.4 China Sexual Dysfunction Drugs Consumption (2017-2022)
-
7.5 Japan Sexual Dysfunction Drugs Consumption (2017-2022)
-
7.6 India Sexual Dysfunction Drugs Consumption (2017-2022)
-
7.7 South Korea Sexual Dysfunction Drugs Consumption (2017-2022)
8 Region and Country-wise Sexual Dysfunction Drugs Market Analysis and Outlook to 2028
-
8.1 Global Sexual Dysfunction Drugs Consumption Forecast (2022-2028)
-
8.2 United States Sexual Dysfunction Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Sexual Dysfunction Drugs Consumption Forecast (2022-2028)
-
8.4 China Sexual Dysfunction Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Sexual Dysfunction Drugs Consumption Forecast (2022-2028)
-
8.6 India Sexual Dysfunction Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Sexual Dysfunction Drugs Consumption Forecast (2022-2028)
9 Global Sexual Dysfunction Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Sexual Dysfunction Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Intracavernosal Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Transurethral Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Sexual Dysfunction Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Male Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Female Consumption and Growth Rate (2017-2022)
10 Global Sexual Dysfunction Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Sexual Dysfunction Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Intracavernosal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Transurethral Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Sexual Dysfunction Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Male Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Female Consumption Forecast and Growth Rate (2022-2028)
11 Global Sexual Dysfunction Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Sexual Dysfunction Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Sexual Dysfunction Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Sexual Dysfunction Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Sexual Dysfunction Drugs Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline Sexual Dysfunction Drugs Product and Service
-
14.2 Teva Pharmaceutical Industries
-
14.2.1 Teva Pharmaceutical Industries Company Details
-
14.2.2 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Sexual Dysfunction Drugs Product and Service
-
14.4 Eli Lilly
-
14.4.1 Eli Lilly Company Details
-
14.4.2 Eli Lilly Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly Sexual Dysfunction Drugs Product and Service
-
14.5 Emotional Brain
-
14.5.1 Emotional Brain Company Details
-
14.5.2 Emotional Brain Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Emotional Brain Sexual Dysfunction Drugs Product and Service
-
14.6 S1 Biopharma
-
14.6.1 S1 Biopharma Company Details
-
14.6.2 S1 Biopharma Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 S1 Biopharma Sexual Dysfunction Drugs Product and Service
-
14.7 Apricus Biosciences
-
14.7.1 Apricus Biosciences Company Details
-
14.7.2 Apricus Biosciences Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Apricus Biosciences Sexual Dysfunction Drugs Product and Service
-
14.8 Bayer
-
14.8.1 Bayer Company Details
-
14.8.2 Bayer Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bayer Sexual Dysfunction Drugs Product and Service
-
14.9 Leadiant Biosciences
-
14.9.1 Leadiant Biosciences Company Details
-
14.9.2 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Leadiant Biosciences Sexual Dysfunction Drugs Product and Service
-
14.10 NexMed
-
14.10.1 NexMed Company Details
-
14.10.2 NexMed Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 NexMed Sexual Dysfunction Drugs Product and Service
-
14.11 Takeda
-
14.11.1 Takeda Company Details
-
14.11.2 Takeda Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Takeda Sexual Dysfunction Drugs Product and Service
-
14.12 Vietstar Biomedical Research
-
14.12.1 Vietstar Biomedical Research Company Details
-
14.12.2 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Product and Service
-
14.13 Ivix LLX
-
14.13.1 Ivix LLX Company Details
-
14.13.2 Ivix LLX Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Ivix LLX Sexual Dysfunction Drugs Product and Service
-
14.14 Merck
-
14.14.1 Merck Company Details
-
14.14.2 Merck Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Merck Sexual Dysfunction Drugs Product and Service
-
14.15 AbbVie
-
14.15.1 AbbVie Company Details
-
14.15.2 AbbVie Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 AbbVie Sexual Dysfunction Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Sexual Dysfunction Drugs
-
Figure Sexual Dysfunction Drugs Picture
-
Table Global Sexual Dysfunction Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sexual Dysfunction Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sexual Dysfunction Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Sexual Dysfunction Drugs Consumption by Country (2017-2022)
-
Figure United States Sexual Dysfunction Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Sexual Dysfunction Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Sexual Dysfunction Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Sexual Dysfunction Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Sexual Dysfunction Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Sexual Dysfunction Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Sexual Dysfunction Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Sexual Dysfunction Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Sexual Dysfunction Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Sexual Dysfunction Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Sexual Dysfunction Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Sexual Dysfunction Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Sexual Dysfunction Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Intracavernosal Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Transurethral Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Male Consumption and Growth Rate (2017-2022)
-
Figure Global Female Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intracavernosal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transurethral Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Male Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Female Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Sexual Dysfunction Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Sexual Dysfunction Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Sexual Dysfunction Drugs Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Sexual Dysfunction Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Sexual Dysfunction Drugs Product and Service
-
Table Emotional Brain (Foundation Year, Company Profile and etc.)
-
Table Emotional Brain Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emotional Brain Sexual Dysfunction Drugs Product and Service
-
Table S1 Biopharma (Foundation Year, Company Profile and etc.)
-
Table S1 Biopharma Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table S1 Biopharma Sexual Dysfunction Drugs Product and Service
-
Table Apricus Biosciences (Foundation Year, Company Profile and etc.)
-
Table Apricus Biosciences Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apricus Biosciences Sexual Dysfunction Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Sexual Dysfunction Drugs Product and Service
-
Table Leadiant Biosciences (Foundation Year, Company Profile and etc.)
-
Table Leadiant Biosciences Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Leadiant Biosciences Sexual Dysfunction Drugs Product and Service
-
Table NexMed (Foundation Year, Company Profile and etc.)
-
Table NexMed Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table NexMed Sexual Dysfunction Drugs Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Sexual Dysfunction Drugs Product and Service
-
Table Vietstar Biomedical Research (Foundation Year, Company Profile and etc.)
-
Table Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vietstar Biomedical Research Sexual Dysfunction Drugs Product and Service
-
Table Ivix LLX (Foundation Year, Company Profile and etc.)
-
Table Ivix LLX Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ivix LLX Sexual Dysfunction Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Sexual Dysfunction Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Sexual Dysfunction Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Sexual Dysfunction Drugs Product and Service
-
